Beverly A. Blazar

1.2k total citations · 1 hit paper
23 papers, 919 citations indexed

About

Beverly A. Blazar is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Beverly A. Blazar has authored 23 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 15 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Beverly A. Blazar's work include Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Beverly A. Blazar is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Beverly A. Blazar collaborates with scholars based in United States and Sweden. Beverly A. Blazar's co-authors include Gloria H. Heppner, Daniel L. Dexter, Zuzana Fligiel, Marshall Strome, Linda Sutton, George Klein, E. Klein, Fred R. Miller, Palmer Q. Bessey and Mary L. Rodrick and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Beverly A. Blazar

22 papers receiving 832 citations

Hit Papers

Heterogeneity of tumor cells from a single mouse mammary ... 1978 2026 1994 2010 1978 100 200 300 400

Peers

Beverly A. Blazar
Janet M.D. Plate United States
Kevin A. Myers United Kingdom
Jacki Kornbluth United States
Harry W. Findley United States
H. Terry Wepsic United States
J E Green United States
Richard DeMarco United States
Janet M.D. Plate United States
Beverly A. Blazar
Citations per year, relative to Beverly A. Blazar Beverly A. Blazar (= 1×) peers Janet M.D. Plate

Countries citing papers authored by Beverly A. Blazar

Since Specialization
Citations

This map shows the geographic impact of Beverly A. Blazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly A. Blazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly A. Blazar more than expected).

Fields of papers citing papers by Beverly A. Blazar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly A. Blazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly A. Blazar. The network helps show where Beverly A. Blazar may publish in the future.

Co-authorship network of co-authors of Beverly A. Blazar

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly A. Blazar. A scholar is included among the top collaborators of Beverly A. Blazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly A. Blazar. Beverly A. Blazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farney, Alan C., Eleftherios S. Xenos, David E.R. Sutherland, et al.. (1993). Inhibition of pancreatic islet beta cell function by tumor necrosis factor is blocked by a soluble tumor necrosis factor receptor.. PubMed. 25(1 Pt 2). 865–6. 39 indexed citations
2.
Blazar, Beverly A., et al.. (1990). Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: comparison of endogenous factors and interleukin-1. Clinical & Experimental Immunology. 80(1). 62–68. 9 indexed citations
3.
Blazar, Beverly A., et al.. (1989). Circulating immune complexes and chemotherapy response in patients with head and neck cancer. Head & Neck. 11(5). 431–436. 8 indexed citations
4.
Strome, Marshall, et al.. (1987). T-Cell Subsets and Natural Killer Cell Function With Squamous Cell Carcinoma of the Head and Neck. Archives of Otolaryngology - Head and Neck Surgery. 113(10). 1090–1093. 14 indexed citations
5.
Blazar, Beverly A., Mary L. Rodrick, JOHN B. OʼMAHONY, et al.. (1986). Suppression of natural killer-cell function in humans following thermal and traumatic injury. Journal of Clinical Immunology. 6(1). 26–36. 67 indexed citations
6.
Blazar, Beverly A., Naomi Galili, & Eva Klein. (1984). Effects of isolated tumor lymphocytes alone and with adherent cells. Cancer Immunology Immunotherapy. 18(3). 179–84. 4 indexed citations
7.
Blazar, Beverly A., Linda Sutton, & Marshall Strome. (1983). Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.. PubMed. 43(10). 4562–8. 91 indexed citations
8.
Blazar, Beverly A., J. Ross Fitzgerald, Linda Sutton, & Marshall Strome. (1983). Increased sensitivity to natural killing in Raji cells is due to effector recognition of molecules appearing on target cell membranes following EBV cycle induction.. PubMed. 54(1). 31–8.
9.
Blazar, Beverly A., et al.. (1980). Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays.. PubMed. 65(2). 405–10. 20 indexed citations
10.
Blazar, Beverly A., et al.. (1980). Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.. The Journal of Experimental Medicine. 151(3). 614–627. 78 indexed citations
12.
Patarroyo, Manuel E., Beverly A. Blazar, Gary R. Pearson, Eva Klein, & George Klein. (1980). Induction of the EBV cycle in B‐lymphocyte‐derived lines is accompanied by increased natural killer (NK) sensitivity and the expression of EBV‐related antigen(s) detected by the ADCC reaction. International Journal of Cancer. 26(3). 365–371. 24 indexed citations
13.
Blazar, Beverly A., et al.. (1979). In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.. PubMed. 122(6). 2180–3. 4 indexed citations
14.
Blazar, Beverly A., et al.. (1979). In Situ Lymphoid Cells of Mouse Mammary Tumors. The Journal of Immunology. 122(6). 2180–2183. 3 indexed citations
15.
Wei, Wei‐Zen, Fred R. Miller, Beverly A. Blazar, Dan Medina, & Gloria H. Heppner. (1979). Opposing Effects of Cryostat Sections of Preneoplastic and Neoplastic Mouse Mammary Lesions on in vitro Migration of Peritoneal Exudate Cells. The Journal of Immunology. 122(5). 2059–2067. 3 indexed citations
16.
Blazar, Beverly A. & Gloria H. Heppner. (1978). In situ lymphoid cells of mouse mammary tumors. II. The characterization of lymphoid cells separated from mouse mammary tumors.. PubMed. 120(6). 1881–6. 17 indexed citations
17.
Blazar, Beverly A., Fred R. Miller, & Gloria H. Heppner. (1978). In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors.. PubMed. 120(6). 1887–91. 17 indexed citations
18.
Dexter, Daniel L., et al.. (1978). Heterogeneity of tumor cells from a single mouse mammary tumor.. PubMed. 38(10). 3174–81. 471 indexed citations breakdown →
19.
Blazar, Beverly A. & Gloria H. Heppner. (1978). In situ lymphoid cells of mouse mammary tumors. I. Development and evaluation of a method for the separation of lymphoid cells from mouse mammary tumors.. PubMed. 120(6). 1876–80. 14 indexed citations
20.
Blazar, Beverly A. & Gloria H. Heppner. (1978). In Situ Lymphoid Cells of Mouse Mammary Tumors. The Journal of Immunology. 120(6). 1881–1886. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026